Russia's Protek launches IPO road show
This article was originally published in Scrip
Executive Summary
One of Russia's largest pharmaceutical companies, Protek, has announced a price range $3.10-4.50 per share for its international offering of up to 130 million of its ordinary shares. The offering is estimated to raise around $400 million.